Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PMD
11851
DELISTED
Psychemedics Corporation
PMD
| $49.7K | ﹤0.01% |
21,509
+8,869
| +70% | +$19.9K |
2023 Q3
4 quarters
|
|
11852
CALL
Custom Truck One Source
CTOS
$2.08B
| $49.7K | ﹤0.01% |
+14,400
| New | +$60.5K |
2024 Q3
0 quarters
|
|
11853
DiaMedica Therapeutics
DMAC
$453M
| $49.6K | ﹤0.01% |
11,831
+3,418
| +41% | +$12.6K |
2021 Q1
14 quarters
|
|
11854
PUT
Comtech Telecommunications
CMTL
$36.9M
| $49.5K | ﹤0.01% |
10,300
+2,600
| +34% | +$8.52K |
2022 Q4
7 quarters
|
|
11855
Reborn Coffee
REBN
$17.6M
| $49.5K | ﹤0.01% |
+16,623
| New | +$69.8K |
2024 Q3
0 quarters
|
|
11856
CALL
Merchants Bancorp
MBIN
$2.26B
| $49.5K | ﹤0.01% |
1,100
-1,800
| -62% | -$79.8K |
2022 Q4
7 quarters
|
|
11857
BTC Digital
BTCT
$18.5M
| $49.4K | ﹤0.01% |
29,967
-5,152
| -15% | -$8.74K |
2024 Q2
1 quarter
|
|
11858
PUT
Lloyds Banking Group
LYG
$77.5B
| $49.3K | ﹤0.01% |
15,800
+2,600
| +20% | +$7.8K |
2020 Q4
15 quarters
|
|
11859
PUT
Alto Ingredients
ALTO
$287M
| $49.3K | ﹤0.01% |
30,600
+7,200
| +31% | +$10.8K |
2020 Q3
16 quarters
|
|
|
NPKI
11860
PUT
NPK International
NPKI
$969M
| $49.2K | ﹤0.01% |
7,100
+7,000
| +7,000% | +$53.9K |
2023 Q2
5 quarters
|
|
11861
CALL
Disc Medicine
IRON
$2.39B
| $49.1K | ﹤0.01% |
1,000
-4,900
| -83% | -$230K |
2023 Q4
3 quarters
|
|
|
TEF
11862
CALL
DELISTED
Telefonica
TEF
| $49.1K | ﹤0.01% |
+10,100
| New | +$45.9K |
2024 Q3
0 quarters
|
|
|
CIO
11863
PUT
DELISTED
City Office REIT
CIO
| $49.1K | ﹤0.01% |
8,400
-7,200
| -46% | -$40.7K |
2022 Q4
7 quarters
|
|
11864
PUT
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.2B
| $49K | ﹤0.01% |
+700
| New | +$47.3K |
2024 Q3
0 quarters
|
|
|
WHWK
11865
CALL
Whitehawk Therapeutics
WHWK
$203M
| $49K | ﹤0.01% |
23,800
+14,400
| +153% | +$23.3K |
2022 Q1
10 quarters
|
|
|
GOEV
11866
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $49K | ﹤0.01% |
2,489
+1,600
| +180% | +$53.7K |
2023 Q2
5 quarters
|
|
11867
PUT
Lincoln Educational Services
LINC
$726M
| $49K | ﹤0.01% |
4,100
-13,100
| -76% | -$163K |
2023 Q3
4 quarters
|
|
11868
CALL
908 Devices
MASS
$497M
| $48.9K | ﹤0.01% |
14,100
+13,300
| +1,663% | +$59K |
2021 Q3
12 quarters
|
|
11869
CALL
CarParts.com
PRTS
$66.4M
| $48.9K | ﹤0.01% |
5,390
+3,890
| +259% | +$36.8K |
2020 Q3
16 quarters
|
|
11870
CALL
Nordic American Tanker
NAT
$1.77B
| $48.8K | ﹤0.01% |
13,300
+1,200
| +10% | +$4.41K |
2013 Q2
45 quarters
|
|
|
IPHA
11871
Innate Pharma
IPHA
$171M
| $48.7K | ﹤0.01% |
21,267
-2,260
| -10% | -$4.99K |
2024 Q2
1 quarter
|
|
11872
CALL
AdvisorShares Psychedelics ETF
PSIL
$48.7M
| $48.6K | ﹤0.01% |
6,370
+4,490
| +239% | +$41.4K |
2024 Q2
1 quarter
|
|
|
EVA
11873
CALL
DELISTED
Enviva Inc.
EVA
| $48.6K | ﹤0.01% |
120,000
-28,600
| -19% | -$12.5K |
2020 Q4
15 quarters
|
|
|
KYNB
11874
CALL
Kyntra Bio
KYNB
$24.2M
| $48.6K | ﹤0.01% |
4,864
+1,488
| +44% | +$22.5K |
2016 Q2
33 quarters
|
|
11875
CALL
YieldMax AI Option Income Strategy ETF
AIYY
$45.9M
| $48.5K | ﹤0.01% |
520
-200
| -28% | -$20.5K |
2024 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.